Vnitr Lek 2014, 60(11):958-962

Non-pharmacological treatment - results from Poděbrady

Lukáš Zlatohlávek1,*, Michal Vrablík1, Zuzana Urbanová2, Hana Pejšová1, Jaroslav Hubáček3, Richard Češka1
1 III. interní klinika 1. LF UK a VFN Praha, přednosta prof. MUDr. Štěpán Svačina, DrSc., MBA
2 Klinika dětského a dorostového lékařství 1. LF UK a VFN Praha, přednosta prof. MUDr. Jiří Zeman, DrSc.
3 Laboratoř molekulární genetiky IKEM Praha, přednosta MUDr. Jan Piťha, CSc.

Objectives:
The study was aimed to determine risk factors of atherosclerosis after one month lifestyle intervention in overweight/obese children and also FTO and MC4R gene variants associated with obesity.


Design and Methods:
350 non-diabetic Czech children (age 13.7 ± 2.1 years, 163 ± 10.6 cm hight) was examined. Before and after 4 weeks of lifestyle intervention (comprising a reduction of energy intake), biochemical and anthropometrical measurements were performed.

Results:
The mean weight loss achieved was 6.2 ± 2.1 kg (P < 0.001). Significant associations between BMI decrease and FTO and MC4R variants were found. Carriers of the FTO GG genotype and/or MC4R CC genotype lost significantly more body weight in comparison to the non-carriers (P < 0.0009 for BMI and P < 0.002 for body weight). The differences remain significant after adjustment for sex age and baseline values (P = 0.004 for BMI and P = 0.01 for body weight).

Conclusions:
It is necessary to look for the risk individuals with wrong response to the regime intervention. This individuals is necessary early treat with drugs to prevention clinically complications.

Keywords: childhood obesity; components of metabolic syndrome; predisposition; response to intervention

Received: August 31, 2014; Accepted: October 1, 2014; Published: November 1, 2014  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Zlatohlávek L, Vrablík M, Urbanová Z, Pejšová H, Hubáček J, Češka R. Non-pharmacological treatment - results from Poděbrady. Vnitr Lek. 2014;60(11):958-962.
Download citation

References

  1. Zlatohlávek L, Urbanová Z, Vrablík M et al. Sledování faktorů aterokslerózy u obézních dětí. Čes-Slov Pediat 2011; 66(3): 153-156.
  2. Šamánek M, Urbanová Z Výskyt nadváhy a obezity u 7 427 českých dětí vyšetřených v roce 2006. Čes-Slov Pediat 2008; 63(3): 120-126.
  3. Hubacek JA, Pikhart H, Peasey A et al. FTO variant, energy intake, physical activity and basal metabolic rate in Caucasians. The HAPIEE study. Physiol Res 2011; 60(1): 175-183. Go to original source... Go to PubMed...
  4. Haupt A Impact of variation near MC4R on whole-body fat distribution, liver fat, and weight loss. Obesity (Silver Spring) 2009; 17(10): 1942-1945.
  5. Loos RJ, Lindgren CM, Li S et al. Common variants near MC4R are associated with fat mass, weight and risk of obesity. Nat Genet 2008; 40(6): 768-765. Go to original source... Go to PubMed...
  6. Hubacek JA, Pitha J, Adamkova V et al. A common variant in the FTO gene is associated with body mass index in males and postmenopausal females but not in premenopausal females. Czech post-MONICA and 3PMFs studies. Clin Chem Lab Med 2009; 47(4): 387-390. Go to original source... Go to PubMed...
  7. Dlouhá D, Suchánek P, Lánská V et al. Body mass index change in females after short-time life style intervention is not dependent on the FTO polymorphisms. Physiol Res 2011; 60(1): 199-202. Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.